Sign up for free shipping on all website orders, no minimum required, and get exclusive coupons!
Maximum quantity allowed is 999
CAS RN: 138402-11-6 | Product Number: I0859
Irbesartan
Purity: >98.0%(T)(HPLC)
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 1G |
$74.00
|
Contact Us | Contact Us | 22 |
|
|
| 5G |
$214.00
|
Contact Us | Contact Us | 22 |
|
* Items in stock locally typically ship the same day of ordering. Items from Japan stock are able to ship from a US warehouse within 2 weeks after ordering. For additional estimated shipment times, please refer to the Shipping Simulation tool. Note: Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | I0859 |
Purity / Analysis Method
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__5H__2__8N__6O = 428.54 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 138402-11-6 |
| Reaxys Registry Number | 6620400 |
| PubChem Substance ID | 172088930 |
| Merck Index (14) | 5083 |
| MDL Number | MFCD00864464 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| Melting point | 184.0 to 188.0 °C |
| Melting Point | 188 °C |
| Solubility in water | Insoluble |
| Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
| RTECS# | HM2950270 |
| HS Number | 2933.29.2000 |
References
- Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-gamma Activity
- Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
- Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist
- C. Cazaubon, J. Gougat, F. Bousquet, P. Guiraudou, R. Gayraud, C. Lacour, A. Roccon, G. Galindo, G. Barthelemy, B. Gautret, J. Pharmacol. Exp. Ther. 1993, 265, 826.
- Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes
- M. Bourrié, V. Meunier, Y. Berger, G. Fabre, Drug Metab. Dispos. 1999, 27, 288.
References
- Irbesartan: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension
- The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamics considerations (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.
